Cargando…
Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study
BACKGROUND: Providers wish to help patients with prescription costs but often lack drug cost information. We examined whether giving providers formulary and drug cost information was associated with changes in their diabetes patients’ drug costs and use. We conducted a longitudinal non-randomized ev...
Autores principales: | Tseng, Chien-Wen, Lin, Grace A., Davis, James, Taira, Deborah A., Yazdany, Jinoos, He, Qimei, Chen, Randi, Imamura, Allison, Dudley, R. Adams |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031286/ https://www.ncbi.nlm.nih.gov/pubmed/27654857 http://dx.doi.org/10.1186/s12913-016-1752-4 |
Ejemplares similares
-
Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020) -
Cost-Effectiveness Analysis and the Formulary Decision-Making Process
por: Wang, Zhixiao, et al.
Publicado: (2004) -
Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience
por: Bahrin, Nur Liyana Zainal, et al.
Publicado: (2015) -
Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013) -
Alternate Financial Incentives in Multi-tiered Formulary Systems to Improve Accountability for Outcomes
por: Chung, Richard S., et al.
Publicado: (2003)